ArticleMolecular pain
Corrigendum.
Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Jung Ye-Ha, Kim H, Jeon SY, Kwon JM, Lee D, Choi Soo-Hee and Kang Do-Hyung. Aberrant interactions of peripheral measures and neurometabolites with lipids in complex regional pain syndrome using magnetic resonance spectroscopy: A pilot study. Mol Pain 2018; 14: doi: 10.1177/1744806917751323 In this article, the authors inadvertently changed the name of the Lip dependents and forgot to mention the usage of the findings. This is corrected for all the versions of the article and the updated text is mentioned below. The authors regret this error. Lip09-dependent right thalamus and Lip13a-dependent left thalamus may be important to elucidate abnormal interactions between lipids in the central thalamus and peripheral measures in CRPS patients, suggestive of unique mechanisms underlying lipidassociated pathophysiology in CRPS, These findings may be used to develop personalized therapies according to the dominant side of the thalamus (right versus left) and the presence and interactions of specific metabolites.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.